학술논문
MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis.
Document Type
Article
Author
Source
Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS139-S140, 2p
Subject
Language
ISSN
15560864